相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A serum-based DNA methylation assay provides accurate detection of glioma
Thais S. Sabedot et al.
NEURO-ONCOLOGY (2021)
Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges
Atsushi Okano et al.
SCIENTIFIC REPORTS (2021)
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas
Mark W. Youngblood et al.
JOURNAL OF NEUROSURGERY (2020)
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
Thomas Graillon et al.
CLINICAL CANCER RESEARCH (2020)
Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments
Kuo-Shyang Jeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
Farshad Nassiri et al.
NATURE MEDICINE (2020)
The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis
Chongran Sun et al.
FRONTIERS IN ONCOLOGY (2020)
Developmental biology of the meninges
Krishnakali Dasgupta et al.
GENESIS (2019)
Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas
Shuyu Hao et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri et al.
NEURO-ONCOLOGY (2019)
New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses
Aysha AlSahlawi et al.
Oncotarget (2019)
Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome
Annamaria Biczok et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas
Sally R. Williams et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2019)
TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2018)
High-grade meningiomas: biology and implications
Wenya Linda Bi et al.
NEUROSURGICAL FOCUS (2018)
Medical management of meningioma in the era of precision medicine
Saksham Gupta et al.
NEUROSURGICAL FOCUS (2018)
Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms
Dustin T. Proctor et al.
WORLD NEUROSURGERY (2018)
Emerging Medical Treatments for Meningioma in the Molecular Era
Fares Nigim et al.
BIOMEDICINES (2018)
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
Felix Sahm et al.
LANCET ONCOLOGY (2017)
SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas
Julien Boetto et al.
NEURO-ONCOLOGY (2017)
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence
Uemmueguelsuem Yesiloez et al.
NEURO-ONCOLOGY (2017)
BAP1 mutations in high-grade meningioma: implications for patient care
Ganesh M. Shankar et al.
NEURO-ONCOLOGY (2017)
KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas
Hailiang Tang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
Integrated genomic analyses of de novo pathways underlying atypical meningiomas
Akdes Serin Harmanci et al.
NATURE COMMUNICATIONS (2017)
Genomic landscape of high-grade meningiomas
Wenya Linda Bi et al.
NPJ GENOMIC MEDICINE (2017)
Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers
Jie Zhang et al.
BMC GENOMICS (2017)
Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature
Rachael A. Vaubel et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539
C. Leland Rogers et al.
NEURO-ONCOLOGY (2016)
Brain invasion in otherwise benign meningiomas does not predict tumor recurrence
Peter Baumgarten et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes
Ariel E. Marciscano et al.
JOURNAL OF NEUROSURGERY (2016)
EANO guidelines for the diagnosis and treatment of meningiomas
Roland Goldbrunner et al.
LANCET ONCOLOGY (2016)
Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system
Sayaka Yuzawa et al.
MODERN PATHOLOGY (2016)
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Victoria E. Clarke et al.
NATURE GENETICS (2016)
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma
Malak Abedalthagafi et al.
NEURO-ONCOLOGY (2016)
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
Sherri Z. Millis et al.
JAMA ONCOLOGY (2016)
Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005
Yongli Ji et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond
Achim Breiling et al.
EPIGENETICS & CHROMATIN (2015)
Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
Ziming Du et al.
ONCOTARGET (2015)
The mTOR signaling pathway as a treatment target for intracranial neoplasms
Doreen Pachow et al.
NEURO-ONCOLOGY (2015)
Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas
Miriam J. Smith et al.
JOURNAL OF PATHOLOGY (2014)
Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship
Irina M. Shapiro et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2013)
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2013)
mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models
Doreen Pachow et al.
CLINICAL CANCER RESEARCH (2013)
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas
Miriam J. Smith et al.
NATURE GENETICS (2013)
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K. Brastianos et al.
NATURE GENETICS (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
Kruppel-like factors in cancer
Marie-Pier Tetreault et al.
NATURE REVIEWS CANCER (2013)
Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses
Yugo Kishida et al.
CARCINOGENESIS (2012)
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis
Peter Horak et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
Emil Lou et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri
Pepijn van den Munckhof et al.
NEUROGENETICS (2012)
Posterior Cranial Fossa Meningiomas
Vijayakumar Javalkar et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2012)
Treatment of unresectable skull base meningiomas with somatostatin analogs
Chris Schulz et al.
NEUROSURGICAL FOCUS (2011)
Spectrum of SMARCB1/INI1 Mutations in Familial and Sporadic Rhabdoid Tumors
Katherine W. Eaton et al.
PEDIATRIC BLOOD & CANCER (2011)
Hypomethylation of repeated DNA sequences in cancer
Jason P. Ross et al.
EPIGENOMICS (2010)
Recurrence and regrowth of benign meningiomas
Satoshi Nakasu et al.
BRAIN TUMOR PATHOLOGY (2009)
Microarray-based analysis of spinal versus intracranial meningiomas:: Different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression
Jose Maria Sayagues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The role of focal-adhesion kinase in cancer. A ew therapeutic opportunity
GW McLean et al.
NATURE REVIEWS CANCER (2005)
Chromosomal instability in meningiomas
AAG van Tilborg et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization
A Arslantas et al.
NEUROLOGIA MEDICO-CHIRURGICA (2003)
INI1 mutations in meningiomas at a potential hotspot in exon 9
U Schmitz et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
